Richard S. Levy
2011
In 2011, Richard S. Levy earned a total compensation of $1.4M as Executive Vice President, Chief Drug Development and Medical Officer at Incyte, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $289,356 |
|---|---|
| Option Awards | $720,952 |
| Salary | $352,249 |
| Other | $3,833 |
| Total | $1,366,390 |
Levy received $721K in option awards, accounting for 53% of the total pay in 2011.
Levy also received $289.4K in non-equity incentive plan, $352.2K in salary and $3.8K in other compensation.
Rankings
In 2011, Richard S. Levy's compensation ranked 4,545th out of 10,747 executives tracked by ExecPay. In other words, Levy earned more than 57.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,545 out of 10,747 | 58th |
Division Services | 671 out of 1,597 | 58th |
Major group Engineering, Accounting, Research, Management, And Related Services | 52 out of 172 | 70th |
Industry group Research, Development, And Testing Services | 9 out of 45 | 80th |
Industry Commercial Physical and Biological Research | 9 out of 41 | 78th |
Source: SEC filing on April 22, 2014.
Levy's colleagues
We found four more compensation records of executives who worked with Richard S. Levy at Incyte in 2011.